Hello dear reader! First, I want to apologize for the rate of publication of articles on this blog that has recently slowed down: the correction of my future publication takes me a lot of time, sorry! Also, I want to respond to a comment from a reader: I did not...
Dear reader! So, how is it going this week? Me, more than well: Boston lost (NHL) in the Stanley Cup final – niark, niark! I … No, but no kidding, that cumulated with the victory of the Toronto Raptors (NBA) stamped a smile on face for a few days. :...
Dear members, You are cordially invited to the annual general assembly of the members of Ataxia Canada-Claude St-Jean Foundation. The meeting will be held in Montreal at the Centre for Sustainable Development located at 50 Sainte-Catherine street west, 2nd Floor on Sunday November 18th, 2018 at 1PM. This assembly will...
Resume from the Friedreich’s Ataxia News article, Specific Cytokines Therapy Protected Neurons in Humanized Mouse Study “A cocktail of clinically approved cytokines for other diseases shows promising neuro-protective effects in a Friedreich’s ataxia (FA) humanized mouse model. The study, “Cytokine therapy-mediated neuroprotection in a Friedreich’s ataxia mouse model” was published...
Editorial Information, awareness, communication and action Eldorado, our association’s bulletin has been around for more than 40 years. It is a recognized paper publication which is filed at the Bibliothèque et Archives nationales du Québec, Bibliothèque et Archives Canada and is also published in electronic format. It is a unique...
Québec media have recently covered the story of Jayden, bubble boy, the first Québec patient successfully treated using gene therapy. Jayden Duquette, five months old, was a patient of Dr. Élie Haddad, a pediatric immunologist at Ste-Justine children’s hospital in Montreal. He was born with an immune system deficiency caused...
